Creative Medical Technology (CELZ) Stock Analysis

What Creative Medical Technology does

Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

Key metrics

ETFs linked to CELZ

Broad-market and Healthcare sector ETFs an investor holding Creative Medical Technology is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CELZ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Creative Medical Technology?

Creative Medical Technology trades under the ticker CELZ on NASDAQ.

Which exchange is CELZ listed on?

CELZ is listed on NASDAQ.

What sector does Creative Medical Technology operate in?

Creative Medical Technology is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CELZ in a portfolio?

PortView shows CELZ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.